Announcements

Director Robert L. Zerbe, MD, filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,000 shares of Vericel Corp common stock following a stock option exercise, with the sale to be executed through Fidelity Brokerage Services LLC on NASDAQ.

Cadence Design Systems officer Paul Scannell filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,401 shares of Cadence common stock with an aggregate market value of $768,127.92.

Global Industrial Company officer Manoj Shetty filed a Form 144 notice of proposed sale of 2,000 shares of common stock, dated November 9, 2026, through Morgan Stanley Smith Barney LLC.

Namrata Saroj, Chief Business Officer of Ocular Therapeutix, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 35,370 shares of common stock on November 5, 2026, pursuant to a Rule 10b5-1 automatic sale instruction to cover tax withholding obligations tied …

Franklin Financial Services Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing third-quarter net income of $8,535 thousand and nine-month net income of $21,783 thousand.

Artiva Biotherapeutics, Inc. filed a Form 8-K/A amendment on November 9, 2026, providing cost estimates for its previously announced wind-down of AlloNK development and workforce reduction that were unavailable at the time of the original October 27, 2026 filing.

American Public Education, Inc. filed a Form 8-K with the SEC on November 9, 2026, reporting that it issued a press release covering financial results for the three and nine months ended September 30, 2026.